| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $157K | -80.6% |
| SG&A Expense | $111K | +391.8% |
| Operating Income | -$1.2M | +21.8% |
| Income Tax | $0 | — |
| Net Income | -$1.8M | -192.8% |
| EPS (Basic) | -$0.01 | -200.0% |
| EPS (Diluted) | -$0.01 | -200.0% |
| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $260K | -57.8% |
| Accounts Receivable | $9K | +94.4% |
| Current Assets | $1.3M | -57.9% |
| Total Assets | $1.4M | -57.7% |
| Total Liabilities | $333K | -7.1% |
| Stockholders' Equity | $1.0M | -64.1% |
| Line Item | 2023-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | -25.0% |
| Investing Cash Flow | $855K | -22.3% |
| Financing Cash Flow | $2K | -98.5% |